In re Lidoderm Antitrust Litigation

*1160ORDER GRANTING IN PART AND DENYING IN PART DEFENDANTS’ MOTION TO DISMISS SECOND AMENDED COMPLAINTS

Re: Dkt. No. 139

WILLIAM H. ORRICK, United States District Judge

INTRODUCTION

This case concerns the alleged antitrust and anticompetitive impact of a July 2012 settlement agreement between defendants Endo Pharmaceuticals Inc., Teikoku Seiya-ku Co., Teikoku Pharma USA (collectively “Endo defendants”) and defendant Watson Pharmaceuticals, Inc. (collectively “defendants”), which terminated Watson’s patent litigation lawsuit against the Endo defendants in exchange for the provision of brand-name…